These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 25138250)
1. Enhancement in bioavailability of ketorolac tromethamine via intranasal in situ hydrogel based on poloxamer 407 and carrageenan. Li C; Li C; Liu Z; Li Q; Yan X; Liu Y; Lu W Int J Pharm; 2014 Oct; 474(1-2):123-33. PubMed ID: 25138250 [TBL] [Abstract][Full Text] [Related]
2. Nasal delivery of analgesic ketorolac tromethamine thermo- and ion-sensitive in situ hydrogels. Li X; Du L; Chen X; Ge P; Wang Y; Fu Y; Sun H; Jiang Q; Jin Y Int J Pharm; 2015 Jul; 489(1-2):252-60. PubMed ID: 25957699 [TBL] [Abstract][Full Text] [Related]
3. Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel. Chen X; Zhi F; Jia X; Zhang X; Ambardekar R; Meng Z; Paradkar AR; Hu Y; Yang Y J Pharm Pharmacol; 2013 Jun; 65(6):807-16. PubMed ID: 23647674 [TBL] [Abstract][Full Text] [Related]
4. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Morsi N; Ghorab D; Refai H; Teba H Int J Pharm; 2016 Jun; 506(1-2):57-67. PubMed ID: 27091293 [TBL] [Abstract][Full Text] [Related]
5. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies. M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392 [TBL] [Abstract][Full Text] [Related]
6. Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties. Liu Y; Zhu YY; Wei G; Lu WY Eur J Pharm Sci; 2009 Jun; 37(3-4):306-12. PubMed ID: 19491020 [TBL] [Abstract][Full Text] [Related]
7. A novel formulation of ketorolac tromethamine for intranasal administration: preclinical safety evaluation. Boyer KC; McDonald P; Zoetis T Int J Toxicol; 2010; 29(5):467-78. PubMed ID: 20884857 [TBL] [Abstract][Full Text] [Related]
8. Comparison of intranasal ketorolac tromethamine pharmacokinetics in younger and older adults. Bullingham R; Juan A Drugs Aging; 2012 Nov; 29(11):899-904. PubMed ID: 23143939 [TBL] [Abstract][Full Text] [Related]
9. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine. Qian S; Wong YC; Zuo Z Int J Pharm; 2014 Jul; 468(1-2):272-82. PubMed ID: 24709220 [TBL] [Abstract][Full Text] [Related]
10. Sustained release of ketorolac tromethamine from poloxamer 407/cellulose nanofibrils graft nanocollagen based ophthalmic formulations. Orasugh JT; Dutta S; Das D; Pal C; Zaman A; Das S; Dutta K; Banerjee R; Ghosh SK; Chattopadhyay D Int J Biol Macromol; 2019 Nov; 140():441-453. PubMed ID: 31437512 [TBL] [Abstract][Full Text] [Related]
11. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Zaki NM; Awad GA; Mortada ND; Abd Elhady SS Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822 [TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of ketorolac after single postoperative intranasal administration in adolescent patients. Drover DR; Hammer GB; Anderson BJ Anesth Analg; 2012 Jun; 114(6):1270-6. PubMed ID: 22467894 [TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of nasal formulations of ketorolac. Quadir M; Zia H; Needham TE Drug Deliv; 2000; 7(4):223-9. PubMed ID: 11195429 [TBL] [Abstract][Full Text] [Related]
14. Developing Transdermal Applications of Ketorolac Tromethamine Entrapped in Stimuli Sensitive Block Copolymer Hydrogels. Mallandrich M; Fernández-Campos F; Clares B; Halbaut L; Alonso C; Coderch L; Garduño-Ramírez ML; Andrade B; Del Pozo A; Lane ME; Calpena AC Pharm Res; 2017 Aug; 34(8):1728-1740. PubMed ID: 28540502 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary and nasal deposition of ketorolac tromethamine solution (SPRIX) following intranasal administration. Bacon R; Newman S; Rankin L; Pitcairn G; Whiting R Int J Pharm; 2012 Jul; 431(1-2):39-44. PubMed ID: 22525081 [TBL] [Abstract][Full Text] [Related]
16. Effect of methyl cellulose on gelation behavior and drug release from poloxamer based ophthalmic formulations. Dewan M; Bhowmick B; Sarkar G; Rana D; Bain MK; Bhowmik M; Chattopadhyay D Int J Biol Macromol; 2015 Jan; 72():706-10. PubMed ID: 25256549 [TBL] [Abstract][Full Text] [Related]
17. Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits. Santus G; Rivolta R; Bottoni G; Testa B; Canali S; Peano S Farmaco; 1993 Dec; 48(12):1709-23. PubMed ID: 8135994 [TBL] [Abstract][Full Text] [Related]
18. Effect of salts on gelation and drug release profiles of methylcellulose-based ophthalmic thermo-reversible in situ gels. Bhowmik M; Bain MK; Ghosh LK; Chattopadhyay D Pharm Dev Technol; 2011 Aug; 16(4):385-91. PubMed ID: 20429816 [TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamine. Chelladurai S; Mishra M; Mishra B Chem Pharm Bull (Tokyo); 2008 Nov; 56(11):1596-9. PubMed ID: 18981612 [TBL] [Abstract][Full Text] [Related]
20. The Controlled Release and Anti-Inflammatory Activity of a Tetramethylpyrazine-Loaded Thermosensitive Poloxamer Hydrogel. Xia H; Jin H; Cheng Y; Cheng Z; Xu Y Pharm Res; 2019 Feb; 36(4):52. PubMed ID: 30783816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]